Literature DB >> 18538970

HISS-dependent insulin resistance (HDIR) in aged rats is associated with adiposity, progresses to syndrome X, and is attenuated by a unique antioxidant cocktail.

W Wayne Lautt1, Zhi Ming, M Paula Macedo, Dallas J Legare.   

Abstract

The hypotheses were: HISS-dependent insulin resistance (HDIR) accounts for insulin resistance that occurs with aging; HDIR is the initiating metabolic defect that leads progressively to type 2 diabetes and the metabolic syndrome; a synergistic antioxidant cocktail in chow confers protection against HDIR, subsequent symptoms of diabetes, and the metabolic syndrome. Male Sprague Dawley rats were tested at 9, 26, and 52 weeks to determine their dynamic response to insulin, the HISS (hepatic insulin sensitizing substance)-dependent component of insulin action, and the HISS-independent (direct) insulin action using a dynamic insulin sensitivity test. In young rats, the HISS component accounted for 52.3+/-2.1% of the response to a bolus of insulin (50mU/kg) which decreased to 29.8+/-3.4% at 6 months and 17.0+/-2.7% at 12 months. HISS action correlated negatively with whole body adiposity and all regional fat depots (r(2) = 0.67-0.87). The antioxidants (vitamin C, vitamin E, and S-adenosylmethionine) conferred protection of HISS action, fat mass at all sites, blood pressure, postprandial insulin and glucose. Data are consistent with the hypotheses. Early detection and therapy directed towards treatment of HDIR offers a novel therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18538970      PMCID: PMC2894083          DOI: 10.1016/j.exger.2008.04.013

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  57 in total

1.  Dose-related atropine-induced insulin resistance: comparing intraportal versus intravenous administration.

Authors:  S Takayama; D J Legare; W W Lautt
Journal:  Proc West Pharmacol Soc       Date:  2000

2.  Effect of hepatic denervation on peripheral insulin sensitivity in conscious dogs.

Authors:  Mary Courtney Moore; Shosuke Satake; Bryan Baranowski; Po-Shiuan Hsieh; Doss W Neal; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-02       Impact factor: 4.310

3.  Influence of total vs. visceral fat on insulin action and secretion in African American and white children.

Authors:  M I Goran; R N Bergman; B A Gower
Journal:  Obes Res       Date:  2001-08

Review 4.  Age-related insulin resistance: is it an obligatory finding? The lesson from healthy centenarians.

Authors:  M Barbieri; M R Rizzo; D Manzella; G Paolisso
Journal:  Diabetes Metab Res Rev       Date:  2001 Jan-Feb       Impact factor: 4.876

5.  Hepatic parasympathetic (HISS) control of insulin sensitivity determined by feeding and fasting.

Authors:  W W Lautt; M P Macedo; P Sadri; S Takayama; F Duarte Ramos; D J Legare
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-07       Impact factor: 4.052

Review 6.  Visceral fat and insulin resistance--causative or correlative?

Authors:  K N Frayn
Journal:  Br J Nutr       Date:  2000-03       Impact factor: 3.718

7.  As the gut ages: timetables for aging of innervation vary by organ in the Fischer 344 rat.

Authors:  R J Phillips; T L Powley
Journal:  J Comp Neurol       Date:  2001-06-04       Impact factor: 3.215

Review 8.  The relationship of obesity to the metabolic syndrome.

Authors:  Harold E Lebovitz
Journal:  Int J Clin Pract Suppl       Date:  2003-03

Review 9.  S-Adenosylmethionine: a control switch that regulates liver function.

Authors:  Jose M Mato; Fernando J Corrales; Shelly C Lu; Matias A Avila
Journal:  FASEB J       Date:  2002-01       Impact factor: 5.191

Review 10.  A new paradigm for diabetes and obesity: the hepatic insulin sensitizing substance (HISS) hypothesis.

Authors:  W Wayne Lautt
Journal:  J Pharmacol Sci       Date:  2004-05       Impact factor: 3.337

View more
  6 in total

Review 1.  Risk of postprandial insulin resistance: the liver/vagus rapport.

Authors:  Maria Paula Macedo; Inês S Lima; Joana M Gaspar; Ricardo A Afonso; Rita S Patarrão; Young-Bum Kim; Rogério T Ribeiro
Journal:  Rev Endocr Metab Disord       Date:  2014-03       Impact factor: 6.514

Review 2.  Attenuation of age- and sucrose-induced insulin resistance and syndrome X by a synergistic antioxidant cocktail: the AMIS syndrome and HISS hypothesis.

Authors:  W Wayne Lautt; Zhi Ming; Dallas J Legare
Journal:  Can J Physiol Pharmacol       Date:  2010-03       Impact factor: 2.273

3.  Putative hormone with anti-obesogenic and insulin-sensitizing effect.

Authors:  Ivan Sosa; Aron Grubesic
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-29       Impact factor: 3.219

4.  Fatty Liver and Fatty Heart-Where do They Stand in the AMIS Syndrome?

Authors:  W Wayne Lautt; Zhi Ming; Dallas J Legare; Kawshik K Chowdhury; Grant M Hatch; Hui Helen Wang
Journal:  Healthcare (Basel)       Date:  2015-08-11

Review 5.  Vitamin C: A Review on its Role in the Management of Metabolic Syndrome.

Authors:  Sok Kuan Wong; Kok-Yong Chin; Soelaiman Ima-Nirwana
Journal:  Int J Med Sci       Date:  2020-06-27       Impact factor: 3.738

Review 6.  Obesity as an Early Symptom of the AMIS Syndrome.

Authors:  W Wayne Lautt; Hui Helen Wang
Journal:  J Clin Med       Date:  2014-10-28       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.